Now, Out of the Blue, Kay Has Stage 3 Breast Cancer and Needs Our Support — Let’s Rally Around Her

Yan-Kay Crystal Lowe Shares Stage 3 Breast Cancer Diagnosis Hallmark actress Yan-Kay Crystal Lowe has revealed her diagnosis of stage 3 invasive ductal carcinoma, the most common form of breast cancer. Lowe, 44, shared the news in a personal essay for PEOPLE magazine, detailing her journey from discovering an undetected mass to beginning treatment. Lowe first noticed a large mass in her right breast in February 2025. Initial screening, including a mammogram and ultrasound, did not detect cancer. However, as the mass grew and migrated over the following months—accompanied by an inverted nipple—further testing led to a biopsy that confirmed invasive ductal carcinoma. Subsequent staging classified her cancer as stage 3. Invasive ductal carcinoma begins in the milk ducts and can spread to surrounding breast tissue. According to the American Cancer Society, nearly 317,000 women in the United States are expected to be diagnosed with invasive breast cancer in 2025. After diagnosis, Lowe’s medical team recommended a treatment plan involving chemotherapy, a double mastectomy, and radiation therapy. She described the diagnosis as overwhelming, particularly as someone without a history of major illness. Lowe emphasized the importance of connecting with others facing similar challenges, noting that shared experiences and practical advice—such as requesting ice chips or saline during chemotherapy—have provided meaningful support. Lowe, a mother of two, has used her platform to encourage others to prioritize breast health and follow up on persistent symptoms, even when initial screenings are negative. Her story highlights the limitations of routine imaging in certain cases and underscores the value of self-advocacy in healthcare. Through her openness, Lowe aims to foster community and awareness around breast cancer, particularly for women navigating diagnoses later in life or after childbirth. She continues to share updates on her health journey via social media, advocating for early detection and emotional resilience during treatment.